ABSTRACT
Objective@#To explore the choice of the best mode of delivery after cesarean section.@*Methods@#From January 2015 to December 2016, the clinical data of 2 526 pregnant women admitted in the Eighth People's Hospital of Taiyuan were retrospectively analyzed.A total of 971 cases were cesarean section, among them, the second cesarean section in 367 cases(control group B), cesarean section vaginal delivery in 604 cases(observation group). At the same period, another 186 cases with non-scar uterine pregnancy by vaginal delivery were selected as control group A. The maternal and child outcomes were compared among the three groups.@*Results@#The time of labor, postpartum hemorrhage, hospital stay, the incidence of neonatal asphyxia in the control group A were (6.30±3.03)h, (288.67±220.67)mL, (1.37±0.72)d, 3.76%, respectively, which in the control group B were (6.30±3.03)h, (415.87±356.20)mL, (4.32±0.83)d, 3.54%, respectively, which in the observation group were (5.98±2.87)h, (276.44±211.84)mL, (1.42±0.65)d, 3.48%, respectively.The postpartum hemorrhage of the control group B was significantly higher than that of the observation group[(415.87±356.20)mL vs.(276.44±211.84)mL], the difference was statistically significant(t=11.271, P<0.05). The length of hospital stay of the control group B was also longer than that of the observation group[(4.32±0.83)d vs.(1.42±0.65)d], the difference was statistically significant(t=18.034, P<0.05).@*Conclusion@#In the condition of emergency intercourse with cesarean section, it is safe and feasible to give the vagina trial to the pregnancy of cesarean section which meets the conditions of vaginal delivery.
ABSTRACT
Objective To investigate the effects of telmisartan in treatment of hypertrophy and diastolic function of left ventricular in patients with hypertension and left ventricular. Methods A total of 78 patients admitted to our hospital with primary hypertension and myocardial hypertrophy and left ventricular diastolic dysfunction from April 2013 to May 2014 were selected as the research objects, and they were given telmisartan tablets orally, the differences of diastolic blood pressure (DBP), systolic blood pressure (SBP) changes and the ultrasonic heartbeat of each index recorded before and after treatment, recorded the heart function classification as well were compared. Results ①After the treatment, systolic and diastolic blood pressure were (107.6±9.9) mmHg and (73.3±5.2) mmHg, compared with the data of before treatment (153.5±12.6) mmHg and(98.9±8.0) mmHg, decreased significantly and there were statistical differences(P<0.05); ②After the treatment, left ventricular posterior wall thickness, index interventricular septum thickness, left ven-tricular end diastolic diameter, left ventricular mass index and late diastolic mitral flow velocity A were significantly lower than that before treatment (P<0.05); Early diastolic mitral flow velocity peak E increased significantly (P<0.05);③After treatment, the number of grade Ⅰ from 24 patients before treatment increased to 62 cases, cardiac function significantly improved after treatment(P<0.05). Conclusion The significant effect on primary hypertension and myocar-dial hypertrophy and left ventricular diastolic dysfunction by oral telmisartan, is worth the clinical promotion.
